StonvexLoading…
StonvexStonvexStonvexCore line items from PAHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.12B | $737.80M | $363.89M | $1.30B |
Operating Income | $146.24M | $101.59M | $51.26M | $110.47M |
Net Income | $78.01M | $53.99M | $26.53M | $48.26M |
EPS (Diluted) | $1.90 | $1.32 | $0.65 | $1.19 |
Total Assets | $1.45B | $1.41B | $1.39B | $1.36B |
Total Liabilities | $1.08B | $1.07B | $1.07B | $1.08B |
Cash & Equivalents | $54.93M | $55.49M | $72.77M | $68.04M |
Free Cash Flow OCF − CapEx | $4.64M | $3.75M | $-4.50M | $41.83M |
Shares Outstanding | 40.96M | 40.92M | 40.88M | 40.68M |